Ligand Pharmaceuticals
Update in progressLGND (NasdaqGM)
- Company RatingNeutralCompany RatingCombines sentiment and sustainability signals into an overall assessment of the company.Great · Good · Neutral · At Risk · Poor
- SectorHealthcare
- IndustryBiotechnology
Ligand Pharmaceuticals Incorporated is a biopharmaceutical company that develops and licenses pharmaceutical assets worldwide. Its portfolio spans infectious disease, cancer, immunology, neurology, cardiology, ophthalmology, respiratory and rare diseases, including products such as Pradefovir, Posaconazole, Voriconazole, EVOMELA, KYPROLIS, FILSPARI, VAXNEUVANCE, VEKLURY, and others. Founded in 1987, it is based in Jupiter, Florida.
Company score
- Sentiment
- 0.22
- SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
- Environment
- 0.00
- EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
- Social
- 0.11
- Governance
- 0.03
- GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
- Sustainability
- 0.04
- SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
- Impact Score
- 0.13
- Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive
Company
- MarketNasdaqGM (NGM)
- LocationUnited States
- CEOMr. Todd C. Davis Ph.D.
- Founded1987
- Employees47
- Websitewww.ligand.com
Identifiers
- ISINUS53220K5048
- FIGIBBG000BKF014
- LEI5493008K7TB0IKP37H79
- CUSIP53220K173
- CIK0000886163